The mutational constraint spectrum quantified from variation in 141,456 humans
2020 · Nature · 9,856 citations
https://doi.org/10.1038/s41586-020-2308-7
H
Harry Sokol
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
657
Papers
63.1K
Citations
100
h-index
298
i10-index
Harry Sokol is an academic researcher from Harvard University. The author has contributed to research in topics: Gut microbiota and health & Inflammatory Bowel Disease & Clostridium difficile and Clostridium perfringens research. The author has an h-index of 100, co-authored 559 publications.
ORCID: 0000-0002-2914-1822Papers by this author
works<i>Faecalibacterium prausnitzii</i> is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 · Proceedings of the National Academy of Sciences · 4,217 citations
https://doi.org/10.1073/pnas.0804812105
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 · Cell Host & Microbe · 2,777 citations
https://doi.org/10.1016/j.chom.2018.05.003
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
2012 · Genome biology · 2,695 citations
https://doi.org/10.1186/gb-2012-13-9-r79
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
2020 · Nature Reviews Gastroenterology & Hepatology · 1,879 citations
https://doi.org/10.1038/s41575-019-0258-z
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
2009 · BMC Microbiology · 1,709 citations
https://doi.org/10.1186/1471-2180-9-123
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat